AlphaYouVRXA: Hosseinion Warren discloses a purchase
By AlphaYouPublished Form 4
Hosseinion Warren
Reporting filer
Hosseinion Warren reported Purchase in Veraxa Biotech AG: 6024 units of Ordinary Shares, dated 2026-09-10. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 29, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Hosseinion Warren | 2026-09-10 | P | Purchase | 6024 | 1.67 | 634,692 | 19 days | Filed terms
|
Ordinary Shares
- Owner
- Hosseinion Warren
- Date
- 2026-09-10
- Code
- P
- Action
- Purchase
- Quantity
- 6024
- Price
- 1.67
- Following holdings
- 634,692
- Reporting delay
- 19 days
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-09-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 6024
- transaction Price Per Share: 1.67
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 634692
- id: F1
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Hosseinion Warren: Director.
- F1: The reported securities reflect the forfeiture of 71,332 Ordinary Shares of Veraxa Biotech AG (the "Company"), par value CHF 1/113.25, for no additional consideration, in connection with the Company's business combination consummated on June 10, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.